Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)

SHE:002370 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	776.79	743.85	720.47	757.62	821.11	902.94
Cash & Short-Term Investments	776.79	743.85	720.47	757.62	821.11	902.94
Cash Growth	17.14%	3.25%	-4.90%	-7.73%	-9.06%	-23.50%
Accounts Receivable	121.86	111.68	111.8	115.65	85.24	160.71
Other Receivables	24.37	26.4	29.19	15.14	1.18	116.35
Receivables	146.22	138.08	140.99	130.79	86.42	277.06
Inventory	80.22	70.13	89.47	95.2	60.9	64.88
Other Current Assets	1.4	3.1	4.24	21.23	27.41	29.97
Total Current Assets	1,005	955.16	955.18	1,005	995.85	1,275
Property, Plant & Equipment	331.16	338.11	364.79	385.89	433.99	487.75
Long-Term Investments	36.75	38.49	37.75	40.96	58.27	75.14
Other Intangible Assets	52.75	54.2	59.21	57.22	51.57	49.95
Long-Term Deferred Tax Assets	-	-	-	0.25	-	-
Long-Term Deferred Charges	15.77	15.82	11.37	22.14	71.1	68.65
Other Long-Term Assets	-	-	1.08	12.56	-	-
Total Assets	1,441	1,402	1,429	1,524	1,611	1,956
Accounts Payable	66.63	45.77	51.8	89.83	53.93	44.95
Accrued Expenses	6.41	17.08	16.98	22.73	21.65	25.42
Short-Term Debt	30.03	30.06	50.06	50.06	-	-
Current Portion of Long-Term Debt	270.46	301.7	-	-	110.16	-
Current Portion of Leases	-	-	-	1.7	1.35	-
Current Income Taxes Payable	1	-	-	-	-	-
Current Unearned Revenue	6.32	2.23	7.96	14.47	2.77	3.61
Other Current Liabilities	49.7	19.6	35.01	43.58	24.3	217.54
Total Current Liabilities	430.55	416.44	161.8	222.38	214.15	291.52
Long-Term Debt	-	-	639.48	900.01	861.58	930.44
Long-Term Leases	-	-	-	-	1.34	-
Long-Term Unearned Revenue	4.06	4.36	5.56	6.83	15.16	10.88
Long-Term Deferred Tax Liabilities	3.65	3.86	3.61	3.55	5.94	3.17
Other Long-Term Liabilities	4.93	4.93	38.04	89.83	79.65	59.91
Total Liabilities	443.19	429.59	848.5	1,223	1,178	1,296
Common Stock	739.63	728.59	609.17	536.69	536.62	536.56
Additional Paid-In Capital	1,936	1,907	1,594	1,310	1,309	1,308
Retained Earnings	-1,735	-1,727	-1,761	-1,749	-1,616	-1,388
Comprehensive Income & Other	56.32	63.35	138.8	203.57	203.8	204.01
Total Common Equity	997.86	972.18	580.87	301.27	432.96	660.41
Shareholders' Equity	997.86	972.18	580.87	301.27	432.96	660.41
Total Liabilities & Equity	1,441	1,402	1,429	1,524	1,611	1,956
Total Debt	300.49	331.75	689.54	951.78	974.43	930.44
Net Cash (Debt)	476.31	412.1	30.94	-194.16	-153.31	-27.5
Net Cash Growth	1690.04%	1232.00%	-	-	-	-
Net Cash Per Share	0.66	0.60	0.05	-0.37	-0.29	-0.05
Filing Date Shares Outstanding	739.63	728.59	609.17	536.69	536.62	536.56
Total Common Shares Outstanding	739.63	728.59	609.17	536.69	536.62	536.56
Working Capital	574.08	538.72	793.38	782.46	781.7	983.32
Book Value Per Share	1.35	1.25	0.72	0.18	0.81	1.23
Tangible Book Value	945.11	917.99	521.67	244.04	381.39	610.46
Tangible Book Value Per Share	1.28	1.17	0.63	0.07	0.71	1.14
Buildings	-	429.39	427.32	413.92	426.8	380.62
Machinery	-	224.35	221.97	220.86	221.01	239.6
Construction In Progress	-	0.03	0.03	-	0.9	44.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.